Levent Öztekin is currently the Business Unit Director at DEVA, focusing on Oncology, Ophthalmology, Immunology, and Central Nervous System sectors. Previously, they served as the Oncology & Hematology Franchise Head at Takeda from 2023 to 2025. Levent's extensive background in the pharmaceutical industry also includes various roles at SANOFI, where they contributed as a Marketing Manager and Senior Brand Manager, among other positions, from 2012 to 2013. Prior to that, they held multiple sales and marketing roles, enhancing their expertise in oncology and immunology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices